Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidolCUBEDDU, L. X; HOFFMANN, I. S; JAMES, M. K et al.The Journal of pharmacology and experimental therapeutics. 1983, Vol 226, Num 3, pp 680-685, issn 0022-3565Article

BROMOCRIPTINTHERAPIE = BROMOCRIPTINEKOENIG MP.1981; SCHWEIZ. MED. WOCHENSCHR.; ISSN 0036-7672; CHE; DA. 1981; VOL. 111; NO 9; PP. 303-308; ABS. ENG; BIBL. 18 REF.Article

SYNTHESE UND EIGENSCHAFTEN VON BROMOCRIPTIN. = SYNTHESE ET PROPRIETES DE LA BROMOCRYPTINESCHNEIDER HR; STADLER PA; STUTZ P et al.1977; EXPERIENTIA; SUISSE; DA. 1977; VOL. 33; NO 11; PP. 1412-1413; ABS. ANGL.; BIBL. 6 REF.Article

Bromocriptine-responsive idiopathic edemaZIMLICHMAN, R. R; PORATH, A; SOBEL, R et al.Israel journal of medical sciences. 1984, Vol 20, Num 3, pp 264-266, issn 0021-2180Article

Primary tissue culture of human adrenocortical Conn's adenomata: bromocriptine as a possible agonist-antagonist of angiotensin at the cellular levelARMATO, U; MANTERO, F.Cell and tissue research. 1984, Vol 236, Num 1, pp 67-72, issn 0302-766XArticle

Severity of Parkinsońs disease and the dosage of bromocriptineLARSEN, T. A; NEWMAN, R; LEWITT, P et al.Neurology. 1984, Vol 34, Num 6, pp 795-797, issn 0028-3878Article

Low-dose bromocriptine therapy in Parkinson's diseasePFEIFFER, R. F; WILKEN, K; GLAESKE, C et al.Archives of neurology (Chicago). 1985, Vol 42, Num 6, pp 586-588, issn 0003-9942Article

Essai de la bromocriptine dans le traitement de l'autisme infantile = Use of bromocriptene in child autism treatmentSIMON-SORET, C; BORENSTEIN, P.La Presse médicale (1983). 1987, Vol 16, Num 26, issn 0755-4982, 1286Article

Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolideGOETZ, C. G; TANNER, C. M; GLANTZ, R. H et al.Neurology. 1985, Vol 35, Num 5, pp 749-751, issn 0028-3878Article

Bromocriptine in the management of end of dose deterioration in Parkinson's diseaseGRIMES, J. D; KING, D. B; KOFMAN, O. S et al.Canadian journal of neurological sciences. 1984, Vol 11, Num 4, pp 452-456, issn 0317-1671Article

Syndromes dépressifs en gériatrie: intérêt de l'association clomipramine-bromocriptine = Depression in geriatry: advantage of the association clomipramine-bromocriptineBROCKER, P; BENSENIOR, H; LODS, J. C et al.La Revue de gériatrie. 1983, Vol 8, Num 8, pp 385-388, issn 0397-7927Article

Bromocriptine inhibition of hyperprolactinemia during surgeryJULLIEN, Y; ROCHETTE, A; DESCH, G et al.Acta obstetricia et gynecologica Scandinavica. 1985, Vol 64, Num 5, pp 403-405, issn 0001-6349Article

Pregnancy despite continued elevation of prolactin levels while on bromergocryptineCORSON, S. L; BATZER, F. R.International journal of gynaecology and obstetrics. 1985, Vol 23, Num 2, pp 105-107, issn 0020-7292Article

Pituitary apoplexy in an acromegalic patient during bromocriptine therapyALHAJJE, A; LAMBERT, M; CRABBE, J et al.Journal of neurosurgery. 1985, Vol 63, Num 2, pp 288-292, issn 0022-3085Article

Bromocriptine treatment in patients with late onset acne and idiopathic hyperprolactinemiaPESERICO, A; RUZZA, G; VELLER FORNASA, C et al.Acta dermato-venereologica. 1988, Vol 68, Num 1, pp 83-84, issn 0001-5555Article

Medical management of hyperprolactinemia: a lower dose of bromocriptine may be effectiveSOTO-ALBORS, C. E; RANDOLPH, J. F; YING, Y.-K et al.Fertility and sterility. 1987, Vol 48, Num 2, pp 213-217, issn 0015-0282Article

The effect of bromocriptine in the polycystic ovary syndromeSPRUCE, B. A; KENDALL-TAYLOR, P; DUNLOP, W et al.Clinical endocrinology (Oxford. Print). 1984, Vol 20, Num 4, pp 481-488, issn 0300-0664Article

Case-control cytogenetic study in offspring of mothers treated with bromocriptine during early pregnancyCZEIZEL, A; KISS, R; RACZ, K et al.Mutation research. 1989, Vol 210, Num 1, pp 23-27, issn 0027-5107Article

Assessment by computed tomography of the response of pituitary macroadenomas to bromocriptineCHAKERA, T. M. H; KHANGURE, M. S; PULLEN, P et al.Clinical radiology. 1985, Vol 36, Num 3, pp 223-226, issn 0009-9260Article

Cerebrospinal fluid rhinorrhea during treatment with bromocriptine for prolactinomaKOK, J. G; BARTELINK, A. K. M; SCHULTE, B. P. M et al.Neurology. 1985, Vol 35, Num 8, pp 1193-1195, issn 0028-3878Article

Accidental bromocriptine ingestion in childhoodVERMUND, S. H; GOLDSTEIN, R. G; ROMANO, A. A et al.The Journal of pediatrics. 1984, Vol 105, Num 5, pp 838-840, issn 0022-3476Article

Fibrose pleuro-pulmonaire et bromocriptine = Pleuropulmonary fibrosis and bromocriptineVERGERET, J; BARAT, M; TAYTARD, A et al.La Semaine des hôpitaux de Paris. 1984, Vol 60, Num 11, pp 741-744, issn 0037-1777Article

Morphological changes in bromocriptine-treated pituitary tumoursANNIKO, M; WERSALL, J.Acta oto-laryngologica. 1983, Vol 96, Num 3-4, pp 337-353, issn 0001-6489Article

I NUOVI INIBITORI DELLA LATTAZIONE = LES NOUVEAUX INHIBITEURS DE LA LACTATIONBAGNOLI P; ZOCCHI G.1979; MINERVA GINECOL.; ITA; DA. 1979; VOL. 31; NO 4; PP. 245-250; ABS. ENG; BIBL. 21 REF.Article

INHIBITION OF LACTATION IN RABBITS BY 2-BR-ALPHA -ERGOKRYPTINE-MESILATE (CB 154)FLUECKIGER E; BILLETER E; WAGNER HR et al.1976; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1976; VOL. 26; NO 1; PP. 51-53; ABS. ALLEM.; BIBL. 14 REF.Article